跳至主要内容
临床试验/ACTRN12613000165785
ACTRN12613000165785已完成3 期

A single-blinded randomised controlled trial to determine the effect of topical application of Calendula officinalis based lotion on the prevalence of clinically significant radiation induced dermatitis in women undergoing radiotherapy for breast cancer.

Dr Michael Penniment0 个研究点目标入组 178 人开始时间: 2013年2月11日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
178

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Women who have undergone lumpectomy or mastectomy and are due to undergo post-surgical radiotherapy for
  • breast cancer using standard treatment pathways
  • No concurrent chemotherapy
  • Informed consent

排除标准

  • Known allergy to calendula/officinalis or sorbolene
  • Salicylate sensitivity
  • Previous radiation to breast
  • History of skin/dermatitis condition
  • On anticoagulant therapy
  • Pregnant or breast feeding
  • Reaction to skin test

研究者

发起方
Dr Michael Penniment

相似试验